Dr. Thomas Edward Cataldo, MD

Dr. Cataldo practices at Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health.

Dr. Cataldo's NPI, 1144226366, was assigned on June 22, 2005. Dr. Cataldo graduated from UMass Chan Medical School in 1990. Dr. Cataldo's Rhode Island license number on file is MD11660.

Dr. Cataldo's primary practice is Beth Israel Deaconess Medical Center, at 330 Brookline Avenue, Boston, MA 02215 in Suffolk County. The practice phone is (617) 667-7000.

Dr. Cataldo's primary practice is Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health. Dr. Cataldo is also affiliated with Beth Israel Deaconess Hospital-Needham. The medical group on file is Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP). Dmand AI also links Dr. Cataldo to 1 more hospital, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cataldo practices, 4 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Cataldo's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Cataldo is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Cataldo's licenses on file in 5 states: Rhode Island, Massachusetts, Pennsylvania, New Jersey and Louisiana.

Dmand AI lists colonoscopy, colon removal, gastrointestinal obstruction and hemorrhoids among the conditions Dr. Cataldo treats.

CMS data shows 248 Medicare services from Dr. Cataldo across 6 procedure codes in 2024, for 191 Medicare patients. Medicare paid $17,015 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 191 Medicare patients who saw Dr. Cataldo in 2024. The largest group is 65 to 74, with 87 patients. 73% of them have high cholesterol, and 68% have high blood pressure. 21% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cataldo's median patient age at 66, with 48% women.

In 2024, Dr. Cataldo wrote 62 Medicare Part D claims for 41 patients. 89% of them were for generic drugs. CMS names the drug for 19 of them, across 1 drug with 11 or more claims each, at $39 in total drug cost. In 2023, CMS named 28 claims across 2 drugs.

Dr. Cataldo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cataldo as offering telehealth. CMS counts 12 procedures of colonoscopy by Dr. Cataldo, more than 42% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 22 papers to Dr. Cataldo, published from 2018 to 2023. 2022 was the busiest year, with 7. The most frequent topics are Colectomy, Postoperative Complications and Rectal Neoplasms. Dr. Cataldo has published most often in Am Surg. Dr. Cataldo's most frequent co-authors are Evangelos Messaris, MD, PhD, Anne Fabrizio, MD and Vitaliy Y. Poylin, MD.

CMS Open Payments shows 4 general payments to Dr. Cataldo from 3 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 60% of the total. Covidien LP paid the most, $325.

Dmand AI lists 1 award for Dr. Cataldo.

Dr. Cataldo graduated from UMass Chan Medical School in 1990. Dr. Cataldo is a member of ACS, ASCRS and SLS.

Dr. Cataldo is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.